Status: Not yet recruiting
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
The primary objective of the study is to assess the safety and efficacy of DA-001 as a treatment for Hair Shedding Reduction and Hair Re-Growth
Participants needed: 1,120
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Apr 13, 2026
Eligibility criteria
Age 18 or older [+4]
A medical history that may interfere with study objectives [+7]